GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

getagozumab   Click here for help

GtoPdb Ligand ID: 14322

Synonyms: GMA-301 | GMA301
Compound class: Antibody
Comment: Getagozumab (GMA301; Gmax Biopharm) is a humanized IgG4 anti-endothelin receptor A (ETA) monoclonal antibody. It acts as an antagonist of receptor function [1].
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
No information available.
Summary of Clinical Use Click here for help
Getagozumab (GMA301) was progressed as a clinical candidate for the treatment of pulmonary arterial hypertension.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04505137 A Study to Investigate Safe and Tolerable Dose of GMA301 Injection in Healthy Volunteers Phase 1 Interventional Gmax Biopharm LLC.